Among Sino Biological’s 1,100+ recombinant cytokines, their GMP-grade stem cell research cytokines ... importance of sex-specific in vitro models for neurological research and drug discovery. In this ...

Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA service, delivering ...

Charles River Laboratories International, Inc. and Akron Bio ("Akron"), a leading supplier of critical materials and services for advanced therapies, today announced the integration of Akron's Closed ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...

Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic ...

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters ...

Inhibition of protein phosphatase 1 by other drugs or siRNA also increased cell-surface calreticulin. Both of these approaches, as well as recombinant ... through cytokine treatment, may also ...

Blood DC antigen 2 (BDCA2) is exclusively expressed on pDCs and its antibody BIIB059 has demonstrated preliminary efficacy and excellent safety in patients with SLE or cutaneous lupus erythematosus ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

They examined how this can influence the release of more than 90 kinds of cytokines, a type of signalling ... "We may also be able to include cancer-fighting drugs that target the tumor in the ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...